Alicia C. J.
- Country
- Spain
- Department
- 1212:Oncología Médica
Research Overview
- A Phase I Study of SIE-1 in Post-menopausal Women with Hormone Receptor-positive Early Breast Cancer
- Comparison of RO7771950 plus combination therapy versus tucatinib plus combination therapy in pretreated HER2-positive locally advanced or metastatic breast cancer
- Efficacy and Safety of Giredestrant vs. Fulvestrant with CDK4/6 Inhibitor in ER+ HER2- Advanced Breast Cancer Resistant to Endocrine Therapy
Data & Insights
Has run more than one trial at 118 of 293 partner sites.
Specializations
Breast Cancer Specialization
This investigator focuses extensively on various types of breast cancer treatments, particularly in advanced and metastatic settings. Their research encompasses multiple breast cancer subtypes including HER2-positive, hormone receptor-positive, and triple-negative breast cancer.
- Targeted Therapies and Immunotherapies
- Endocrine Treatment Approaches
- Neoadjuvant Therapy Strategies
Lung Cancer Research
The investigator specializes in treating non-small cell lung cancer, with particular emphasis on cases involving specific genetic mutations. Their work includes studies of novel therapeutic approaches for patients with EGFR mutations.
- Advanced and Metastatic NSCLC
- Targeted Molecular Therapies
- Combination Treatment Strategies
Advanced Solid Tumors
The investigator conducts research on various types of advanced solid tumors, including innovative approaches in endometrial cancer treatment. Their work encompasses both early-phase and late-phase clinical trials.
- Novel Therapeutic Compounds
- Immunotherapy Applications
- Precision Medicine Approaches
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.